Validation of a commercial enzyme immunoassay to assess urinary oxytocin in humans.

analytical validation degradation human urine immunogram peptide hormone repeatability storage

Journal

Endocrine connections
ISSN: 2049-3614
Titre abrégé: Endocr Connect
Pays: England
ID NLM: 101598413

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 21 01 2021
accepted: 17 02 2021
pubmed: 23 2 2021
medline: 23 2 2021
entrez: 22 2 2021
Statut: ppublish

Résumé

Within the last decade, oxytocin (OT) has attracted a lot of attention in the context of various human social behaviors. Besides its importance in regulating physiological processes in females related to giving birth and lactation, OT is involved in the establishment and maintenance of social relationships, trust and emotion recognition. However, results are not always consistent across studies, which may partly be due to the incomplete validation of methods used to assess OT levels. Carefully validating a method before its use is of crucial importance to ensure that it can be used to accurately, reliably and repeatedly assess OT levels. With this study we evaluated a commercially available Enzyme Immunoassay to assess OT in human urine samples by conducting a careful analytical validation. Results indicate that, with regard to parallelism and immunoreactivity, human urinary OT can be assessed reliably. However, extraction methods need further improvement to optimize measures of accuracy and extraction efficiency, especially in the lower range of the assay system. Tests on OT stability indicate that OT is affected by degradation when stored at 4°C or room temperature. Storing urine samples over longer periods revealed that OT levels are most stable when stored as ethanol extracts at -20°C compared to being stored as samples at -20°C or -80°C. Although some of the validated parameters did not reach the intended quality criteria, this study highlights the importance of such in depth validation procedures and reporting results to make them available to researchers embarking on projects utilizing such methods.

Identifiants

pubmed: 33617463
doi: 10.1530/EC-20-0583
pii: EC-20-0583.R1
pmc: PMC8052582
doi:
pii:

Types de publication

Journal Article

Langues

eng

Pagination

290-301

Références

Psychosom Med. 2011 Jun;73(5):393-400
pubmed: 21636661
Physiol Behav. 2005 Mar 16;84(3):445-8
pubmed: 15763582
Annu Rev Psychol. 2014;65:17-39
pubmed: 24050183
Pharm Res. 2009 Jul;26(7):1679-88
pubmed: 19343484
Psychophysiology. 2008 May;45(3):349-52
pubmed: 18266803
Mol Psychiatry. 2015 Sep;20(9):1085-90
pubmed: 25349162
Proc Biol Sci. 2013 Jan 23;280(1755):20122765
pubmed: 23345575
Hum Brain Mapp. 2014 Sep;35(9):4741-50
pubmed: 24659430
Front Neurosci. 2017 Sep 21;11:524
pubmed: 28983237
J Neuroendocrinol. 2016 Apr;28(4):
pubmed: 26991328
Gen Comp Endocrinol. 2019 Sep 15;281:73-82
pubmed: 31121163
Horm Behav. 2010 Feb;57(2):255-62
pubmed: 20025881
Neuroscience. 2018 Jan 15;369:292-302
pubmed: 29183825
Neuropsychopharmacology. 2013 Sep;38(10):1929-36
pubmed: 23575742
Biol Psychiatry. 2016 Feb 1;79(3):251-7
pubmed: 26210057
Psychoneuroendocrinology. 2012 Mar;37(3):438-43
pubmed: 21802859
J Clin Endocrinol Metab. 1987 Feb;64(2):340-5
pubmed: 3793853
Sci Rep. 2015 Nov 09;5:16308
pubmed: 26549509
Neurosci Biobehav Rev. 2013 Sep;37(8):1485-92
pubmed: 23665533
Ann N Y Acad Sci. 2007 Mar;1098:312-22
pubmed: 17435137
Gen Comp Endocrinol. 2013 Jan 1;180:33-8
pubmed: 23142266
Psychoneuroendocrinology. 2013 Jul;38(7):1208-12
pubmed: 23507187
Horm Behav. 2019 Nov;116:104581
pubmed: 31449811
Neurosci Biobehav Rev. 2017 Jul;78:117-124
pubmed: 28442403
Nature. 2005 Jun 2;435(7042):673-6
pubmed: 15931222
J Pharm Biomed Anal. 2007 Jan 4;43(1):270-6
pubmed: 16884883
Psychopharmacology (Berl). 2013 Oct;229(4):639-51
pubmed: 23624810
Am J Primatol. 2018 Oct;80(10):e22871
pubmed: 29756649
J Endocrinol. 2016 Oct;231(1):1-10
pubmed: 27460343
Biol Psychiatry. 2016 Feb 1;79(3):243-50
pubmed: 26049207
Horm Behav. 2007 Mar;51(3):436-42
pubmed: 17292369
PLoS One. 2014 Aug 18;9(8):e103677
pubmed: 25133536
Horm Behav. 2017 May;91:3-18
pubmed: 28202354
Horm Behav. 2018 Sep;105:28-40
pubmed: 30031684
Gen Comp Endocrinol. 2010 Aug 1;168(1):1-7
pubmed: 20412809
J Gerontol B Psychol Sci Soc Sci. 2014 Nov;69 Suppl 2:S229-37
pubmed: 25360024
Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):268-273
pubmed: 28028227
J Hum Evol. 2014 Jan;66:83-8
pubmed: 24275194
Brain Res. 1987 Jun 23;414(1):133-7
pubmed: 3620914
J Endocrinol. 2012 Jul;214(1):55-65
pubmed: 22562655
Rev Reprod. 1997 Jan;2(1):28-37
pubmed: 9414463
Mol Med Today. 1997 Jun;3(6):269-75
pubmed: 9211418
Endocrinology. 1964 Feb;74:226-32
pubmed: 14122528
Dev Sci. 2011 Jul;14(4):752-61
pubmed: 21676095
J Neurosci. 1991 Jul;11(7):2032-8
pubmed: 1648603
J Neuroendocrinol. 2016 Oct;28(10):
pubmed: 27467712

Auteurs

Franka S Schaebs (FS)

Interim Group Primatology, Max Planck Institute for Evolutionary Anthropology, Leipzig, Saxony, Germany.
ZLS, University of Leipzig, Leipzig, Saxony, Germany.

Gwen Wirobski (G)

Domestication Lab, Wolf Science Center, Konrad Lorenz Institute of Ethology, University of Veterinary Medicine Vienna, Vienna, Austria.

Sarah Marshall-Pescini (S)

Domestication Lab, Wolf Science Center, Konrad Lorenz Institute of Ethology, University of Veterinary Medicine Vienna, Vienna, Austria.

Friederike Range (F)

Domestication Lab, Wolf Science Center, Konrad Lorenz Institute of Ethology, University of Veterinary Medicine Vienna, Vienna, Austria.

Tobias Deschner (T)

Interim Group Primatology, Max Planck Institute for Evolutionary Anthropology, Leipzig, Saxony, Germany.

Classifications MeSH